Skip to content

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery

A Double-blind, Placebo-Controlled, Randomized, Comparison Study of the Efficacy of Celebrex 400 mg Single Dose Pre and Celebrex 200 mg Post Ambulatory Arthroscopic Knee Surgery for Total Analgesic Use After Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00633386
Enrollment
200
Registered
2008-03-12
Start date
2003-02-28
Completion date
2003-08-31
Last updated
2021-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopy

Keywords

Knee Surgery, Arthroscopic Surgery

Brief summary

To compare the total analgesic use at 24 hours after arthroscopic knee surgery in patients treated with celecoxib versus placebo.

Interventions

DRUGCelecoxib

400 mg oral capsule as a single dose 1 hour prior to surgery and 200 mg oral capsule as a single dose as needed post-surgery

OTHERPlacebo

Matched placebo

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed knee meniscus pathology requiring ambulatory arthroscopic meniscectomy or partial meniscectomy * Willing to participate in study for 36 hours and come to follow-up visit 7 days post-surgery

Exclusion criteria

* Osteoarthritis, inflammatory arthritis, or previous fracture of index joint * Received acetaminophen or low-dose narcotic within 8 hours of surgery * Have received oral (4 weeks), intramuscular (2 months), intra-articular (3 months) or soft-tissue (2 months) injections of corticosteroids of the first dose of study medication or received intra-articular injections of hyaluronic acid in the index joint within 9 months of the first dose of study medication

Design outcomes

Primary

MeasureTime frame
Total analgesic use after surgery24 hours

Secondary

MeasureTime frame
Number and percentage of subjects taking analgesic (hydrocodone bitartrate 5 mg/acetaminophen 500 mg [HC/APAP]) after surgery1, 2, 6, 8, 10, 12, 24, and 36 hours
Time to analgesic use after surgery1, 2, 6, 8, 10, 12, 24, and 36 hours
Cumulative number of HC/APAP tablets taken after first dose of study medication1, 2, 6, 8, 10, 12, 36 hours and Day 2
Vital signsDay 7
Physical examinationDay 7
Change in volumetric measurement of both knees from prior to surgeryDay 7
Patient Treatment Satisfaction Scales after surgery24 hours
Adverse eventsDay 7
Patient's Assessment of Knee Pain, according to visual analogue scale at rest and with movement after surgery1, 2, 6, 8, 10, 12, 24 and 36 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026